Characterization of a new specific mPGES-1 inhibitor in cardiovascular system
Xinchun Lin, Huiying Feng, Jin-Rui Zhang, Malarvizhi Gurusamy, Saeed Nasseri, Anton Pekcec, Dongmei Wu · 2025
Read Characterization of a new specific mPGES-1 inhibitor in cardiovascular system by Xinchun Lin, Huiying Feng, Jin-Rui Zhang, Malarvizhi Gurusamy, Saeed Nasseri, Anton Pekcec, Dongmei Wu (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12748921.txt.
Description
Xinchun Lin and co-authors test a targeted heart drug in mice bred to carry the human version of its target enzyme in a 2025 study. The drug blocks mPGES-1, a maker of an inflammatory fat signal, aiming to avoid the heart risks of older pain drugs. Mice received it before or after a blocked heart artery mimicked a heart attack.
Drug-treated mice showed less heart swelling and better pumping, with no change in survival. An older comparison drug raised deaths when given after the attack. The new drug also slowed vessel wall cells and reduced scar-like growth after artery injury. The profile supports safer long-term use.
Catalog record
| CREATOR | Xinchun Lin, Huiying Feng, Jin-Rui Zhang, Malarvizhi Gurusamy, Saeed Nasseri, Anton Pekcec, Dongmei Wu |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |